Skip to main content

Positron Emission Tomography (PET)

Image
By

Positron Emission Tomography (PET)

Positron Emission Tomography is a functional imaging technique that uses radioactive substances known as radiotracers to visualize and measure changes in metabolic processes, and in other physiological activities including blood flow, regional chemical composition, and absorption. They use different tracers for different imaging, depending on the target process within the body. We inject a radiopharmaceutical—a radioisotope attached to a drug—into the body as a tracer. Gamma cameras emit and detect Gamma rays to form a three-dimensional image, similar to that of an X-ray image. Positron-emission tomography scanners can incorporate a computerized tomography scanner, and we call them positron-emission tomography-computerized tomography scanners. One disadvantage of a positron-emission tomography scanner is its high initial cost and ongoing operating costs.

Applications

Positron-emission tomography can give information about:

  1. Metabolic changes
  2. Regional cerebral blood flow
  3. Ligand binding

Clinical Uses 

We can use positron-emission tomography in the assessment of several neurological conditions. It is especially helpful for differentiating dementia of Alzheimer's type from frontotemporal dementias. 

  1. Cerebrovascular disease
  2. Alzheimer’s disease
  3. Epilepsy, prior to neurosurgery
  4. Head injury

Panic Disorder

Studies have shown decreased activity in the right parahippocampal region.

Obsessive-compulsive Disorder

Hypermetabolism in the orbitofrontal cortex and caudate nucleus; normalizes with treatment

  1. Bailey DL, Townsend DW, Valk PE, Maisy MN (2005). Positron Emission Tomography: Basic Sciences. Secaucus, NJ: Springer-Verlag. ISBN 978-1-85233-798-8.
  2. Carlson N (January 22, 2012). Physiology of Behavior. Methods and Strategies of Research. 11th edition. Pearson. p. 151. ISBN 978-0205239399."
Labels:

Comments

Post a Comment

Your Thoughts?

Popular posts from this blog

ADVOKATE: A Mnemonic Tool for the Assessment of Eyewitness Evidence

By
ADVOKATE: A Mnemonic Tool for Assessment of Eyewitness Evidence A tool for assessing eyewitness  ADVOKATE is a tool designed to assess eyewitness evidence and how much it is reliable. It requires the user to respond to several statements/questions. Forensic psychologists, police or investigative officer can do it. The mnemonic ADVOKATE stands for: A = amount of time under observation (event and act) D = distance from suspect V = visibility (night-day, lighting) O = obstruction to the view of the witness K = known or seen before when and where (suspect) A = any special reason for remembering the subject T = time-lapse (how long has it been since witness saw suspect) E = error or material discrepancy between the description given first or any subsequent accounts by a witness.  Working with suspects (college.police.uk)
Post a Comment
Read more

ICD-11 Criteria for Anorexia Nervosa (6B80)

By
ICD-11 Criteria for Anorexia Nervosa (6B80) Anorexia Nervosa is characterised by significantly low body weight for the individual’s height, age and developmental stage that is not due to another health condition or to the unavailability of food. A commonly used threshold is body mass index (BMI) less than 18.5 kg/m2 in adults and BMI-for-age under 5th percentile in children and adolescents. Rapid weight loss (e.g. more than 20% of total body weight within 6 months) may replace the low body weight guideline as long as other diagnostic requirements are met. Children and adolescents may exhibit failure to gain weight as expected based on the individual developmental trajectory rather than weight loss. Low body weight is accompanied by a persistent pattern of behaviours to prevent restoration of normal weight, which may include behaviours aimed at reducing energy intake (restricted eating), purging behaviours (e.g. self-induced vomiting, misuse of laxatives), and behaviours aimed at incr
Post a Comment
Read more

ICD-11 Criteria for Schizophrenia (6A20 )

By
ICD-11 Criteria for Schizophrenia (6A20 ) Schizophrenia is characterised by disturbances in multiple mental modalities, including thinking (e.g., delusions, disorganisation in the form of thought), perception (e.g., hallucinations), self-experience (e.g., the experience that one's feelings, impulses, thoughts, or behaviour are under the control of an external force), cognition (e.g., impaired attention, verbal memory, and social cognition), volition (e.g., loss of motivation), affect (e.g., blunted emotional expression), and behaviour (e.g., behaviour that appears bizarre or purposeless, unpredictable or inappropriate emotional responses that interfere with the organisation of behaviour). Psychomotor disturbances, including catatonia, may be present. Persistent delusions, persistent hallucinations, thought disorder, and experiences of influence, passivity, or control are considered core symptoms. Symptoms must have persisted for at least one month in order for a diagnosis of schi
Post a Comment
Read more